Home » Topics » Regulatory » Patents

Patents
RSS

AstraZeneca describes VLA-5 antagonists for the treatment of cancer

Oct. 13, 2009

Novel TpoR agonists in early development at Shanghai Hengrui

Oct. 13, 2009

New compounds for the treatment of obesity claimed by University of Strathclyde

Oct. 13, 2009

Muscarinic M3 receptor antagonists claimed by AstraZeneca and Argenta Discovery

Oct. 9, 2009

Novel Jak2 inhibitors disclosed by Rigel for the treatment of cancer

Oct. 9, 2009

Novel antibacterial agents described by LEAD Therapeutics

Oct. 9, 2009

Synta Pharmaceuticals discloses Hsp70 inducers for the treatment of cancer

Oct. 8, 2009

CRTH2 antagonists for the treatment of asthma presented by Abbott

Oct. 8, 2009

Novel iron chelators described by BTG

Oct. 8, 2009

Chugai Pharmaceutical describes novel PI3Kalpha inhibitors as oncolytics

Oct. 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...